INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 47 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,332,000 | -0.1% | 287,051 | +0.9% | 0.00% | 0.0% |
| Q3 2016 | $4,337,000 | -91.1% | 284,590 | -77.4% | 0.00% | -92.0% |
| Q2 2016 | $48,832,000 | +38.3% | 1,257,910 | -0.9% | 0.05% | +35.1% |
| Q1 2016 | $35,305,000 | -45.3% | 1,269,972 | +5.9% | 0.04% | -45.6% |
| Q4 2015 | $64,497,000 | +36.6% | 1,199,043 | +1.7% | 0.07% | +33.3% |
| Q3 2015 | $47,212,000 | +107.9% | 1,179,105 | +65.9% | 0.05% | +112.5% |
| Q2 2015 | $22,706,000 | -16.1% | 710,660 | -37.3% | 0.02% | -14.3% |
| Q1 2015 | $27,057,000 | +57.8% | 1,133,070 | +16.7% | 0.03% | +64.7% |
| Q4 2014 | $17,142,000 | +28.2% | 971,240 | -0.4% | 0.02% | +30.8% |
| Q3 2014 | $13,369,000 | -25.7% | 975,165 | -8.6% | 0.01% | -23.5% |
| Q2 2014 | $17,982,000 | -6.8% | 1,066,534 | +0.5% | 0.02% | -10.5% |
| Q1 2014 | $19,291,000 | – | 1,061,147 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |